Genetics, Pathophysiology, and Current Challenges in Von Hippel–Lindau Disease Therapeutics.

MLA

Gómez-Virgilio, Laura, et al. “Genetics, Pathophysiology, and Current Challenges in Von Hippel–Lindau Disease Therapeutics.” Diagnostics (2075-4418), vol. 14, no. 17, Sept. 2024, p. 1909. EBSCOhost, https://doi.org/10.3390/diagnostics14171909.

APA

Gómez-Virgilio, L., Velazquez-Paniagua, M., Cuazozon-Ferrer, L., Silva-Lucero, M.-C., Gutierrez-Malacara, A.-I., Padilla-Mendoza, J.-R., Borbolla-Vázquez, J., Díaz-Hernández, J.-A., Jiménez-Orozco, F.-A., & Cardenas-Aguayo, M.-C. (2024). Genetics, Pathophysiology, and Current Challenges in Von Hippel–Lindau Disease Therapeutics. Diagnostics (2075-4418), 14(17), 1909. https://doi.org/10.3390/diagnostics14171909

Chicago

Gómez-Virgilio, Laura, Mireya Velazquez-Paniagua, Lucero Cuazozon-Ferrer, Maria-del-Carmen Silva-Lucero, Andres-Ivan Gutierrez-Malacara, Juan-Ramón Padilla-Mendoza, Jessica Borbolla-Vázquez, Job-Alí Díaz-Hernández, Fausto-Alejandro Jiménez-Orozco, and Maria-del-Carmen Cardenas-Aguayo. 2024. “Genetics, Pathophysiology, and Current Challenges in Von Hippel–Lindau Disease Therapeutics.” Diagnostics (2075-4418) 14 (17): 1909. doi:10.3390/diagnostics14171909.